Baudax Bio Inc

NASDAQ:BXRX   3:59:30 PM EDT
0.75
-0.01 (-1.14%)
Earnings Announcements

Baudax Bio Reports First Quarter 2022 Results

Published: 05/04/2022 21:48 GMT
Baudax Bio Inc (BXRX) - Baudax Bio Reports First Quarter 2022 Financial Results and Business Highlights.
Baudax Bio Reports First Quarter 2022 Financial Results and Business Highlights.
Baudax Bio Inc - As of March 31, 2022, Baudax Bio Had Cash and Cash Equivalents of $11.5 Million.
Baudax Bio Inc - Reported Net Loss of $3.17 per Share, for Three Months Ended March 31, 2022.
Revenue is expected to be $0.77 Million
Adjusted EPS is expected to be -$1.27

Next Quarter Revenue Guidance is expected to be $1.41 Million
Next Quarter EPS Guidance is expected to be -$0.78

More details on our Analysts Page.